Ricevi le ultime notizie sulle azioni Fortress Biotech con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di FBIO

Ultime notizie per

FORTRESS BIOTECH INC

Fortress Biotech

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Fortress Biotech Inc

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Earnings

Press Releases

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

News

Journey Medical Corporation to Present at the Emerging Growth Conference

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Journey Medical Corporation to Participate in September 2025 Investor Conferences

Health Care

Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101

Financing

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics' $205 Million Series A Financing

INVESTOR ALERT: Investigation of Fortress Biotech, Inc. (FBIO) Announced by Holzer & Holzer, LLC

Legal

Fortress Biotech Investigated by the Portnoy Law Firm

Journey Medical Corporation to Participate in October 2025 Investor Conferences

DERM

FBIO

FBIOP

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

aTyr Pharma

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Clene

Connect Biopharma Holdings Limited - Ordinary Shares

Connect Biopharma Hldgs

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Entera Bio

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

InflaRx

Insight Molecular Diagnostics Inc. - Common Stock

Insight Molecular

Immix Biopharma

Immunic

Lite Strategy

NewAmsterdam Pharma Company N.V. - Warrant

NewAmsterdam Pharma Co

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Plus Therapeutics

Pelthos Therapeutics

Quince Therapeutics

Repare Therapeutics

Spruce Biosciences

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

Whitehawk Therapeutics, Inc. - Common Stock

Comments

Fortress Biotech Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO